Displaying 1 - 4 of 4 tests
Octamer Binding Transcription Factor 2 (OCT2) is present in all B-cells expressing Ig. The combination of BOB1 and OCT2 stains is helpful in distinguishing between classical Hodgkin lymphoma (at least one marker negative) and nodular lymphocyte predominant Hodgkin lymphoma (both markers expressed).
Immunohistochemistry (IHC)
Octamer Binding Transcription Factor 4 (OCT4, also known as OCT3/4, POU51) is a transcription factor and is expressed by early embryonic cells, germ cells, and stem cells. OCT4 is a nuclear marker of classical seminoma and embryonal carcinoma. It has excellent sensitivity and specificity for these
Immunohistochemistry (IHC)
Olig2, a transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Olig2 is negative in the non-glial tumors including neuroepithelial tumors, ependymomas, subependymomas,medulloblastomas
Immunohistochemistry (IHC)
Oncomine™ Dx Target Test
The Oncomine Dx Target Test is a next-gen sequencing assay designed to detect variants in 23 genes associated with non-small cell lung cancer (NSCLC). Abnormalities targeted are ROS1 gene fusions and 367 sequence variant "hotspot" mutations in the following genes: AKT1, ALK, BRAF, CDK4, DDR2, EGFR,